Ankylosing Spondylitis News

News

Opioid Use Associated With Fractures in People With Ankylosing Spondylitis

12/20/2023

Increasing age, historical fracture, and opioid use are associated with higher odds of fracture in ankylosing spondylitis (AS), according to a study published in Arthritis Care & Research. “We performed a retrospective cohort study...

Increasing age, historical...

12/20/2023

First Report Managed Care

News

Analysis Finds Similar Safety Profile with Upadacitinib Across Conditions

11/03/2023

Jolynn Tumolo ;

The Janus kinase (JAK) inhibitor upadacitinib offers a similar long-term safety profile across rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD) despite some variations in adverse...

The Janus kinase (JAK) inhibitor...

11/03/2023

First Report Managed Care

News

High Rates of Depression, Anxiety in Patients With Ankylosing Spondylitis

10/06/2023

Jolynn Tumolo ;

Half of patients with ankylosing spondylitis had clinically significant depression, and more than a third had clinically significant anxiety, according to a single-center, cross-sectional study currently underway.

Half of patients with ankylosing...

10/06/2023

First Report Managed Care

News

Achieving Disease Control in PsA, AS Associated with Lower Medical Costs

09/15/2023

Jolynn Tumolo ;

A study published in Rheumatology and Therapy found that individuals diagnosed with psoriatic arthritis (PsA) or ankylosing spondylitis (AS) and exhibiting lower levels of disease activity incurred reduced healthcare resource utilization and...

A study published in...

09/15/2023

First Report Managed Care

News

Fear of Movement in Patients With Ankylosing Spondylitis Linked With Lower Life Quality

07/27/2023

Jolynn Tumolo ;

Research findings indicate a link between kinesiophobia, a fear of movement and injury, and decreased quality of life in patients with ankylosing spondylitis.

Research findings indicate a...

07/27/2023

First Report Managed Care

News

Tildrakizumab No Better Than Placebo for Ankylosing Spondylitis

06/09/2023

Jolynn Tumolo ;

A 48-week trial of tildrakizumab in patients with ankylosing spondylitis was terminated early after researchers found that the drug had no efficacy in comparison to placebo.

A 48-week trial of tildrakizumab...

06/09/2023

First Report Managed Care

News

Risk of Psychiatric Comorbidity Higher in Patients With Ankylosing Spondylitis

05/19/2023

Jolynn Tumolo ;

Findings from a population-based, cross-sectional study suggest that patients with ankylosing spondylitis are at a higher risk of developing psychiatric disorders.

Findings from a...

05/19/2023

First Report Managed Care

News

Short-term Biosimilar Adalimumab Provides Long-term Relief for Ankylosing Spondylitis

04/14/2023

Jolynn Tumolo ;

Treatment with biosimilar adalimumab was associated with a significant improvement in ankylosing spondylitis symptoms for up to 1 year, according to new findings.

Treatment with biosimilar...

04/14/2023

First Report Managed Care

News

JAK Inhibitor Improves Slate of Patient-Reported Outcomes in Biologic Refractory Ankylosing Spondylitis

03/28/2023

Jolynn Tumolo ;

Researchers studied a JAK inhibitor's efficacy for improving disease activity, health-related quality of life, and other measures in a cohort of patients with ankylosing spondylitis who did not respond or tolerate biologics.

Researchers studied a JAK...

03/28/2023

First Report Managed Care

News

Baseline Variables Predict Probability of Initial Response to TNFi Inhibitors in Patients With AS

10/27/2022

Edan Stanley ;

Researchers sought to develop models of the probability of short-term response to tumor necrosis factor inhibitor treatment in patients with ankylosing spondylitis.

Researchers sought to develop...

10/27/2022

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

News

Projections of Hepatitis C and Advanced Liver Disease

10/22/2012

San Diego—Between 2008 and 2015, the number of patients with advanced liver disease is expected to increase from 195,000 to 601,000, with people born from 1945 to 1964 representing >75% of the cases, according to a study of adjudicated...

San Diego—Between 2008 and 2015,...

10/22/2012

First Report Managed Care

News

CMS to Investigate Improper Steering of Medicare, Medicaid Patients to ACA Plans

08/19/2016

The CMS told provider and provider-affliated organizations to stop steering Medicare eligible patients into insurance plans on the ACA Marketplace.

The CMS told provider and...

08/19/2016

First Report Managed Care

News

Categorizing Disease Activity in Ankylosing Spondylitis: SASDAS vs ASDAS

09/09/2022

Jolynn Tumolo ;

Researchers compared the Ankylosing Spondylitis Disease Activity Score to a simplified version of the tool to categorize patients’ disease.

Researchers compared the...

09/09/2022

First Report Managed Care

News Connection

Platelet Inhibition to Bridge Patients for CABG

03/16/2012

Mary Mihalovic ;

The use of cangrelor, an intravenous antagonist of the P2Y12 receptor, to bridge patients after they discontinue antiplatelet therapy in preparation for coronary artery bypass graft (CABG) surgery, was shown to effectively provide platelet...

The use of cangrelor, an...

03/16/2012

First Report Managed Care

News

The Basic Health Program Option under Federal Health Reform: Issues for Consumers and States

04/08/2011

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Ankylosing Spondylitis News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products